Skip to main content

. 1970 Oct 31;4(5730):283–284. doi: 10.1136/bmj.4.5730.283

Reversible encephalopathy and acute renal failure after cephaloridine.

R Gabriel, R D Foord, A M Joekes

PMCID: PMC1819787 PMID: 5475848

283

Images in this article

p284-a
on p.284

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Atkinson R. M., Caisey J. D., Currie J. P., Middleton T. R., Pratt D. A., Sharpe H. M., Tomich E. G. Subacute toxicity of cephaloridine to various species. Toxicol Appl Pharmacol. 1966 May;8(3):407–428. doi: 10.1016/0041-008x(66)90051-2. [DOI] [PubMed] [Google Scholar]
Currie G. A., Little P. J., McDonald S. J. The localisation of cephaloridine and nitrofurantoin in the kidney. Nephron. 1966;3(5):282–288. doi: 10.1159/000179543. [DOI] [PubMed] [Google Scholar]
Curtis J. R., Marshall M. J. Cephaloridine serum levels in patients on maintenance haemodialysis. Br Med J. 1970 Apr 18;2(5702):149–151. doi: 10.1136/bmj.2.5702.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
MURDOCH J. M., SPEIRS C. F., GEDDES A. M., WALLACE E. T. CLINICAL TRIAL OF CEPHALORIDINE (CEPORIN), A NEW BROAD-SPECTRUM ANTIBIOTIC DERIVED FROM CEPHALOSPORIN C. Br Med J. 1964 Nov 14;2(5419):1238–1240. doi: 10.1136/bmj.2.5419.1238. [DOI] [PMC free article] [PubMed] [Google Scholar]
STEWART G. T., HOLT R. J. LABORATORY AND CLINICAL RESULTS WITH CEPHALORIDINE. Lancet. 1964 Dec 19;2(7373):1305–1309. doi: 10.1016/s0140-6736(64)91102-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES